ImmunoGen - Publications - Cancer Treatment and ADC Technology

Publications

There have been numerous presentations and publications on our technology and on compounds developed using it. Publications related to our pipeline are published below.

Compound
Meeting
Title

Pivekimab Sunirine

Meeting
Title

Mirvetuximab Soravtansine

Meeting
Title

Early Pipeline

Meeting
Title

ImmunoGen’s investigational products have not been approved by the U.S. Food and Drug Administration or other regulatory authorities. The safety and efficacy of investigational products have not been established.